Okay, let's tackle this question about the best antihypertensive for a hypertensive diabetic with proteinuria. First, I need to recall the core concept here. Diabetic nephropathy is a common complication in diabetics, and proteinuria is a key marker. The main goal is to protect kidney function and reduce proteinuria. The antihypertensive that's most beneficial in this scenario would be one that also has a renoprotective effect.

The correct answer is likely an ACE inhibitor or an ARB. These drugs are known to reduce intraglomerular pressure and decrease proteinuria, which is why they're first-line in diabetic nephropathy. Let me confirm: ACE inhibitors like lisinopril or ARBs like losartan are recommended. They block the RAAS system, which is overactive in diabetes, leading to reduced glomerular damage.

Now, the wrong options. If the options included beta-blockers, they're not the best choice here because they don't address the underlying renal protection. Thiazide diuretics are okay for hypertension but lack the specific renoprotective benefits. Calcium channel blockers are effective for blood pressure but don't reduce proteinuria as much as ACE/ARBs. So each of these options is less appropriate in this specific context.

The clinical pearl here is that in diabetic patients with proteinuria, ACE inhibitors or ARBs are the first-line treatments due to their dual benefits of blood pressure control and slowing kidney disease progression. Students should remember the mnemonic: "ACE and ARB for diabetic kidneys."

**Core Concept**
The question tests knowledge of antihypertensive selection in diabetic nephropathy. Diabetic kidney disease requires renoprotective agents that reduce glomerular hyperfiltration and proteinuria, primarily via RAAS inhibition.

**Why the Correct Answer is Right**
ACE inhibitors (e.g., lisinopril) or ARBs (e.g., losartan) are first-line in diabetic patients with proteinuria. They block the renin-angiotensin system, lowering intraglomerular pressure, reducing proteinuria, and slowing progression to end-stage renal disease. These drugs are superior to other antihypertensives in preserving kidney function in diabetes.

**Why Each Wrong Option is Incorrect**
**Option A:** Beta-blockers (e.g., metoprolol) decrease blood pressure but lack renoprotective effects and may worsen metabolic parameters in diabetics.
**Option B:** Thiazide diuretics (e.g., hydrochlorothiazide) control hypertension but do not reduce proteinuria or slow diabetic nephropathy.
**Option C:** Calcium channel blockers (e.g., amlodipine) lower blood pressure effectively but lack the RAAS-blocking benefits critical for kidney protection in diabetes.

**Clinical Pearl / High-Yield Fact**
ACE inhibitors and ARBs are the only antihypertensives proven to reduce proteinuria and delay progression of diabetic nephropathy. The mnemonic "ACE & ARB = Diabetic Kidney Guardians" helps recall this key point.

**Correct Answer: C. Angiotensin-Converting Enzyme (ACE) Inhibitor**

✓ Correct Answer: C. Enalapril